Kenta Suto

USPTO Granted Patents = 11 (Patent Applications = 17)

EPO Patents = 1 (Patent Applications = 11)

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486485 - Cell treatment device, suspension culture vessel, and stem cell induction method (2025-12-02),

2. 12454681 - Erythrocyte removal device, mononuclear cell collector, cell culture device, cell culture system, cell culture method, and mononuclear cell collection method (2025-10-28),

3. 12398357 - Cell culture equipment (2025-08-26),

4. 12383583 - Pharmaceutical composition and cosmetic composition (2025-08-12),

5. 12195764 - Method for culturing cells into which reprogramming factor is introduced (2025-01-14),

6. 12036245 - Pharmaceutical composition and cosmetic composition (2024-07-16),

7. 11912977 - Pluripotent stem cell production system (2024-02-27),

8. 11898130 - Cell culture equipment (2024-02-13),

9. 11518974 - Pluripotent stem cell production system (2022-12-06),

10. 11286454 - Pluripotent stem cell manufacturing system and method for producing induced pluripotent stem cells (2022-03-29),

11. 10508260 - Pluripotent stem cell production system (2019-12-17),

Title: Kenta Suto: Innovator in Cell Culture Technology

Introduction

Kenta Suto is a prominent inventor based in Palo Alto, CA, known for his significant contributions to cell culture technology. With a total of 11 patents to his name, Suto has developed innovative devices and methods that enhance the efficiency of cell culture processes.

Latest Patents

Among his latest patents are several groundbreaking inventions, including an erythrocyte removal device, a mononuclear cell collector, and various cell culture devices and methods. One notable method involves introducing a factor into cells within a culture vessel and culturing them in the same vessel. Additionally, he has developed a mononuclear cell collection method that includes treating blood to prepare a treated blood sample, diluting it, allowing sedimentation of mononuclear cells, and subsequently collecting these cells.

Career Highlights

Suto has worked with notable companies such as I Peace, Inc. and Fanuc Corporation, where he has applied his expertise in developing advanced cell culture technologies. His work has significantly impacted the field, providing researchers with improved tools for cell manipulation and analysis.

Collaborations

Throughout his career, Kenta Suto has collaborated with talented individuals, including Koji Tanabe and Brendan Kelly, contributing to the advancement of cell culture methodologies.

Conclusion

Kenta Suto's innovative work in cell culture technology has established him as a key figure in the field. His patents and contributions continue to influence research and development in cellular biology.

This text is generated by artificial intelligence and may not be accurate.